日本薬局方フォーラム
Japanese Pharmacopoeial Forum

Vol. 32 No. 1

March 2023

目

次Contents
改正案

Revision Drafts

第十八改正日本薬局方第二追補に収載予定の改正案（意見募集）
１. 一般試験法(1) 既収載
2.46 残留溶媒 ··············································12.66 元素不純物 ···········································79.41 試薬・試液 ········································· 11
２. 参考情報(1) 新収載
原子間力顕微鏡によるナノ粒子のサイズ及び形態解析法〈G1-9-182〉 ········································· 14
フローサイトメトリー〈G3-16-182〉 ··············· 17
フローイメージング法によるバイオテクノロジー応
用医薬品(バイオ医薬品)原薬／製剤中の不溶性微粒子の評価法〈G3-17-182〉 ······························ 19(2) 既収載
ペプチドマップ法〈G3-3-182〉 ······················· 21
はかり（天秤）に関連する一般試験法改正案及び新規参考
情報案について（意見募集）
１. 一般試験法(1) 既収載
9.62 計量器・用器 ········································ 27
２. 参考情報(1) 新収載
日本薬局方における秤量の考え方〈G1-6-182〉 ·· 27
はかり(天秤)の校正，点検と分銅〈G1-7-182〉 ··· 29
はかり(天秤)の設置環境，基本的な取扱い方法と秤量時の留意点〈G1-8-182〉 ····························· 29
第十八改正日本薬局方第二追補に収載予定の改正案(意見募集)
１. 医薬品各条(化学薬品等)(1) 新収載
アリピプラゾール ········································ 31
オキサリプラチン ········································ 32
オキサリプラチン注射液 ······························· 35
ゲフィチニブ錠 ··········································· 36
ゴセレリン酢酸塩 ········································ 37

トルバプタン ·············································· 39
トルバプタン錠 ··········································· 40
フェブキソスタット ····································· 41
フェブキソスタット錠 ·································· 43
ロルノキシカム ··········································· 45
ロルノキシカム錠 ········································ 47(2) 既収載
カルメロースカルシウム ······························· 49
クリンダマイシンリン酸エステル ··················· 49
シチコリン ················································· 49
タルク ······················································· 50
デキストラン 70 ·········································· 50
テセロイキン(遺伝子組換え) ·························· 51
コムギデンプン ··········································· 55
コメデンプン ·············································· 56
トウモロコシデンプン ·································· 56
バレイショデンプン ····································· 56
ポリスチレンスルホン酸ナトリウム ················ 56
２. 医薬品各条(生薬等)(1) 新収載
辛夷清肺湯エキス ········································ 57(2) 既収載
ゲンチアナ ················································· 59
ゲンチアナ末 ·············································· 59
チョウトウコウ ··········································· 59
バクモンドウ ·············································· 59
抑肝散加陳皮半夏エキス ······························· 60
３. 参照紫外可視吸収スペクトル
アリピプラゾール ········································ 61
オキサリプラチン ········································ 61
トルバプタン ·············································· 61
フェブキソスタット ····································· 61
ロルノキシカム ··········································· 62
４. 参照赤外吸収スペクトル
アリピプラゾール ········································ 62
オキサリプラチン ········································ 62
トルバプタン ·············································· 62
フェブキソスタット ····································· 63

ii

ロルノキシカム ············································63
第十八改正日本薬局方第二追補に収載予定の改正案（報告）１. 医薬品各条(化学薬品等)(1) 既収載
低置換度ヒドロキシプロピルセルロース ···········63
ヒプロメロース ············································64
メチルセルロース ·········································65
既収載品目(医薬品各条(生薬等))の定量法の秤取量(MS)に 「qNMR で含量換算した」を追記する改正について(意見募集)
当帰芍薬散エキス ·········································66
防已黄耆湯エキス ·········································66
ローヤルゼリー ············································66
既収載品目（医薬品各条(生薬等)）の性状における 味記
載の削除について（意見募集）
ベラドンナエキス ·········································66
ホミカエキス ···············································66
ホミカエキス散 ············································66
ホミカチンキ ···············································66
ロートエキス ···············································66
ロートエキス散 ············································67
ロートエキス・アネスタミン散 ·······················67
ロートエキス・カーボン散． ··························67
複方ロートエキス・ジアスターゼ散 ·················67
ブシ配合漢方処方エキスの総アルカロイド定量法の改正について（意見募集）
牛車腎気丸エキス ·········································67
真武湯エキス ···············································67
八味地黄丸エキス ·········································67
第十八改正日本薬局方における元素不純物管理の取込みに伴う 医薬品各条からのヒ素試験の削除について(意見募集)
亜硫酸水素ナトリウム ···································69
乾燥亜硫酸ナトリウム ···································69
グリセリン ··················································69
濃グリセリン ···············································69
軽質無水ケイ酸 ············································69
ケイ酸マグネシウム ······································69
ステアリン酸カルシウム ································69
ステアリン酸ポリオキシル 40 ·························69
ソルビタンセスキオレイン酸エステル ··············69
乾燥炭酸ナトリウム ······································69
炭酸ナトリウム水和物 ···································69
白糖 ···························································69
パラフィン ··················································69
流動パラフィン ············································69
軽質流動パラフィン ······································69
ピロ亜硫酸ナトリウム ···································69
ブドウ糖 ·····················································69
プロピレングリコール ···································69
メグルミン ··················································69

モノステアリン酸アルミニウム ······················ 69
ヨウ化ナトリウム ········································ 69

薬局方関連通知など

Useful Information

第十九改正日本薬局方原案作成要領（一部改正）（案）(意見募集終了) ··············································· 70
日本薬局方収載原案意見募集（令和 5 年 3 月 1 日分）に係るカラム情報の公開について ···················· 192
はかり（天秤）に関連する一般試験法改正案及び新規
参考情報案について ······································ 194

日本薬局方技術情報
Japanese Pharmacopoeial Technical Information

日本薬局方「ウヤク」の鏡検記載の改正経緯について································································· 196

国際調和

Pharmacopoeial Harmonization

１. Stage 2 案 (Official Inquiry Stage Draft)(1) 各条
1)改正①Corn Starch ·········································· 197
２ . 日 米 欧 三 薬 局 方 調 和 合 意 文 書 (HarmonizedDocument)(1) 試験法1)改正・訂正・表紙訂正①Bulk density of powders (Revision 4) ········· 200②Peptide Mapping(Revision 1) ··················· 207③Powder flow(Revision 1) ·························· 225(2) 各条
1)訂正①Carboxymethylcellulose Calcium (Correction 1)······························································ 233② Hydroxypropylcellulose, Low Substituted(Correction 3) ··········································· 238③Hypromellose (Correction 1) ···················· 243④Methylcellulose (Correction 1) ·················· 250⑤Lactose, Anhydrous (Correction 2) ············ 257⑥Lactose, Monohydrate (Correction 2) ········· 263
2)表紙訂正①Calcium Disodium Edetate ······················ 267②Dibasic Calcium Phosphate ····················· 269③Anhydrous Dibasic Calcium Phosphate ····· 271④Croscarmellose Sodium ··························· 273⑤Cellulose, Microcrystalline ······················ 275⑥Cellulose, Powdered ······························· 277⑦Cellulose Acetate Phthalate ····················· 279⑧Citric Acid Anhydrous ···························· 281⑨Citric Acid Monohydrate ························· 283⑩Crospovidone ········································· 285⑪Ethylcellulose ········································ 287⑫Hydroxyethylcellulose····························· 289

iii⑬Hydroxypropylcellulose ··························· 291⑭Hypromellose Phthalate ·························· 293⑮Magnesium Stearate ······························ 295⑯Methyl Parahydroxybenzoate ··················· 297⑰Petrolatum ············································ 299⑱White Petrolatum ·································· 301⑲Polysorbate 80 ······································· 303⑳Povidone ··············································· 305㉑Sodium Chloride ···································· 308㉒Sodium Starch Glycolate ························· 310㉓Stearic Acid··········································· 312㉔Ethyl Parahydroxybenzoate ····················· 314㉕Propyl Parahydroxybenzoate ··················· 316㉖Butyl Parahydroxybenzoate ····················· 318㉗Carmellose ············································ 320㉘Copovidone ··········································· 322㉙Gelatin·················································· 324㉚Glucose Anhydrous/Monohydrate ·············· 326㉛Mannitol ··············································· 328㉜Isomalt ················································· 330

海外薬局方情報

Foreign Pharmacopoeial Information

非無菌製品の微生物管理及び試験の改良 ············· 332

標準品のご案内

Reference Standards

日本薬局方等標準品の頒布のご案内 ·················· 335
USP 標準品の取次販売のご案内 ······················· 345
LGC Standards 社不純物標準物質等および EP 標準品の取次販売のご案内 ···································· 346～～～～～～～～～～～～～～～

Contents in English
Revision Drafts
Revision Drafts for Second Supplement to JP 18
１. General Tests, Processes and Apparatus(1) Revision
2.46 Residual Solvents ꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏ 352
9.41 Reagents, Test Solutions ꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏ 360
２. Official Monographs(1) Addition
Aripiprazole ꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏ 360
Febuxostat ꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏ 362
Febuxostat Tablets ꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏ 364
Gefitinib Tablets ꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏ 366
Goserelin Acetate ꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏ 367
Lornoxicam ꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏ 369
Lornoxicam Tabletsꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏ 372
Oxaliplatin ꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏ 374
Oxaliplatin Injection ꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏ 377
Tolvaptan ꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏ 379
Tolvaptan Tablets ꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏ 381(2) Revision
Low Substituted Hydroxypropylcellulose ꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏ 382
Hypromellose ꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏ 383
Methylcellulose ꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏ 384
３. Official Monographs－Crude Drugs(1) Addition
Shin’iseihaito Extract ꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏ 384(2) Revision
Gentian ꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏ 387
Powdered Gentian ꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏ 387

Ophiopogon Root ꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏ 387
Uncaria Hook ꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏ 388
Yokukansankachimpihange Extract ꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏ 388
４. Infrared Reference Spectra
Febuxostat ꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏ 389
Lornoxicam ꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏ 390
Oxaliplatin ꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏ 390
Tolvaptan ꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏ 390
５. Ultraviolet-visible Reference Spectra
Febuxostat ꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏ 391
Lornoxicam ꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏ 391
Oxaliplatin ꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏ 391
Tolvaptan ꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏ 392
６. General Informatoin(1) Addition
Analyses of Size and Morphology of
Nanoparticles by Atomic Force Microscope <G19-182> ꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏ 392
Evaluation Method of Insoluble Particulate Matter in
Biotechnological Products (Biopharmaceuticals)Drug Substances/Drug Products by Flow Imaging
Method 〈G3-17-182〉 ꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏ 395
Flow Cytometry〈G3-16-182〉 ꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏ 398
Revision and new general information drafts concerningbalances
１. General Tests, Processes and Apparatus(1) Revision
9.62 Measuring Instruments, Appliances ꞏꞏꞏꞏꞏꞏꞏ 401
２. General Informatoin

iv(1) Addition
Calibration, Inspection, and Weight of aweighing instrument (balance) <G1-7-182> ꞏꞏꞏꞏ 402
Concept of Weighing in the JapanesePharmacopoeia <G1-6-182> ꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏ 403
Installation Environment, Basic Handling
Method, and Precautions for Weighing of a
Balance <G1-8-182> ꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏ 405
Revision of the description of crude drugs (addition of
the sentence, “calculated on the basis of the content
obtained by qNMR”, to taken amount (MS) in the
Assay) for listed articles (official monographs) ꞏꞏꞏꞏꞏꞏꞏꞏꞏ 407

Useful Information
Briefing on General Test and General Information related
to Balances ꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏ 408

Reference Standards
PMRJ Reference Standards Ordering Information for
Foreign Users ꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏ 410

Pharmacopoeial Harmonization
１. Stage 2 (Official Inquiry Stage Draft)(1) Monographs
1)Revision①Corn Starchꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏ 197
２. Harmonized Document)(1) Tests
1)Revision①Bulk density of powders (Revision 4) ꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏ 200②Peptide Mapping(Revision 1)ꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏ 207③Powder flow(Revision 1) ꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏ 225(2) Monographs1)Correction①Carboxymethylcellulose Calcium (Correction 1) ꞏꞏ 233② Hydroxypropylcellulose,
Low
Substituted(Correction 3) ꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏ 238③Hypromellose (Correction 1) ꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏ 243④Methylcellulose (Correction 1) ꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏ 250⑤Lactose, Anhydrous (Correction 2) ꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏ 257⑥Lactose, Monohydrate (Correction 2) ꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏ 263
2)Correction of sign-off coversheet①Calcium Disodium Edetate ꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏ 267②Dibasic Calcium Phosphate ꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏ 269③Anhydrous Dibasic Calcium Phosphate ꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏ 271④Croscarmellose Sodium ꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏ 273⑤Cellulose, Microcrystalline ꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏ 275⑥Cellulose, Powdered ꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏ 277⑦Cellulose Acetate Phthalate ꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏ 279⑧Citric Acid Anhydrous ꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏ 281⑨Citric Acid Monohydrate ꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏ 283⑩Crospovidone ꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏ 285⑪Ethylcelluloseꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏ 287⑫Hydroxyethylcellulose ꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏ 289⑬Hydroxypropylcellulose ꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏ 291⑭Hypromellose Phthalate ꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏ 293⑮Magnesium Stearate ꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏ 295⑯Methyl Parahydroxybenzoate ꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏ 297⑰Petrolatum ꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏ 299⑱White Petrolatumꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏ 301⑲Polysorbate 80 ꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏ 303⑳Povidone ꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏ 305㉑Sodium Chloride ꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏ 308㉒Sodium Starch Glycolate ꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏ 310㉓Stearic Acid ꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏ 312㉔Ethyl Parahydroxybenzoateꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏ 314㉕Propyl Parahydroxybenzoate ꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏ 316㉖Butyl Parahydroxybenzoate ꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏ 318㉗Carmellose ꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏ 320㉘Copovidone ꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏ 322㉙Gelatin ꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏ 324㉚Glucose Anhydrous/Monohydrate ꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏ 326㉛Mannitol ꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏ 328㉜Isomalt ꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏꞏ 330

次号（32 巻 2 号）出版月：2023 年 6 月
Publishing Schedule (Vol.32, No.2): June 2023